Literature DB >> 29482439

Chronic exposure to traffic-related air pollution and cancer incidence among 10,000 patients undergoing percutaneous coronary interventions: A historical prospective study.

Gali Cohen1, Ilan Levy2, Jeremy D Kark3, Noam Levin4, Guy Witberg5, Zaza Iakobishvili5, Tamir Bental5, David M Broday2, David M Steinberg6, Ran Kornowski5,7, Yariv Gerber1.   

Abstract

Background Exposure to traffic-related air pollution (TRAP) is considered to have a carcinogenic effect. The authors previously reported a nonsignificant association between TRAP and cancer risk in a relatively small cohort of myocardial infarction survivors. This study assessed whether TRAP exposure is associated with subsequent cancer in a large cohort of coronary patients. Methods & results Consecutive patients undergoing percutaneous coronary interventions in a major medical centre in central Israel from 2004 to 2014 were followed for cancer through 2015. Residential levels of nitrogen oxides (NOx) - a proxy for TRAP - were estimated based on a high-resolution national land use regression model. Cox proportional hazards models were constructed to study relationships with cancer. Among 12,784 candidate patients, 9816 had available exposure data and no history of cancer (mean age, 68 years; 77% men). During a median (25th-75th percentiles) follow-up of 7.0 (3.9-9.3) years, 773 incident cases of cancer (8%) were diagnosed. In a multivariable-adjusted model, a 10-ppb increase in mean NOx exposure was associated with hazard ratios (HRs) of 1.07 (95% confidence interval [CI] 1.00-1.15) for all-site cancer and 1.16 (95% CI 1.05-1.28) for cancers previously linked to TRAP (lung, breast, prostate, kidney and bladder). A stronger association was observed for breast cancer (HR = 1.43; 95% CI 1.12-1.83). Associations were slightly strengthened after limiting the cohort to patients with more precise exposure assessment. Conclusion Coronary patients exposed to TRAP are at increased risk of several types of cancer, particularly lung, prostate and breast. As these cancers are amenable to prevention strategies, identifying highly exposed patients may provide an opportunity to improve clinical care.

Entities:  

Keywords:  Cancer incidence; exposure assessment; percutaneous coronary interventions; traffic-related air pollution

Mesh:

Substances:

Year:  2018        PMID: 29482439     DOI: 10.1177/2047487318760892

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  3 in total

1.  Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: the ELAPSE project.

Authors:  Ole Raaschou-Nielsen; Gerard Hoek; Jie Chen; Sophia Rodopoulou; Maciej Strak; Kees de Hoogh; Tahir Taj; Aslak Harbo Poulsen; Zorana J Andersen; Tom Bellander; Jørgen Brandt; Emanuel Zitt; Daniela Fecht; Francesco Forastiere; John Gulliver; Ole Hertel; Barbara Hoffmann; Ulla Arthur Hvidtfeldt; W M Monique Verschuren; Jeanette T Jørgensen; Klea Katsouyanni; Matthias Ketzel; Anton Lager; Karin Leander; Shuo Liu; Petter Ljungman; Gianluca Severi; Marie-Christine Boutron-Ruault; Patrik K E Magnusson; Gabriele Nagel; Göran Pershagen; Annette Peters; Debora Rizzuto; Yvonne T van der Schouw; Evangelia Samoli; Mette Sørensen; Massimo Stafoggia; Anne Tjønneland; Gudrun Weinmayr; Kathrin Wolf; Bert Brunekreef
Journal:  Br J Cancer       Date:  2022-02-16       Impact factor: 9.075

2.  The Relationship Between the Metabolic Syndrome and the Place of Residence in the Local Community on the Example of the Janów Lubelski District in Eastern Poland: A Population-Based Study.

Authors:  Grzegorz Józef Nowicki; Barbara Ślusarska; Katarzyna Naylor; Andrzej Prystupa; Ewa Rudnicka-Drożak; Ulyana Halyuk; Petro Pokotylo
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-06       Impact factor: 3.168

3.  Assessment of Concentrations of Heavy Metals in Postmyocardial Infarction Patients and Patients Free from Cardiovascular Event.

Authors:  Grzegorz Józef Nowicki; Barbara Ślusarska; Andrzej Prystupa; Eliza Blicharska; Agnieszka Adamczuk; Tomasz Czernecki; Krzysztof Jacek Jankowski
Journal:  Cardiol Res Pract       Date:  2021-01-31       Impact factor: 1.866

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.